|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2011-5-11
|
|
pubmed:abstractText |
Head-and-neck cancer (HNC) is the eighth most common malignancy worldwide. It is often diagnosed late due to a lack of screening methods and overall cure is achieved in <50% of patients. Head-and-neck cancer sufferers often develop a second primary tumour that can affect the entire aero-digestive tract, mostly HNC or lung cancer (LC), making lifelong follow-up necessary.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1532-1827
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1649-55
|
|
pubmed:dateRevised |
2011-8-16
|
|
pubmed:meshHeading |
pubmed-meshheading:21505455-Adult,
pubmed-meshheading:21505455-Aged,
pubmed-meshheading:21505455-Breath Tests,
pubmed-meshheading:21505455-Case-Control Studies,
pubmed-meshheading:21505455-Cross-Sectional Studies,
pubmed-meshheading:21505455-Early Detection of Cancer,
pubmed-meshheading:21505455-Exhalation,
pubmed-meshheading:21505455-Female,
pubmed-meshheading:21505455-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:21505455-Head and Neck Neoplasms,
pubmed-meshheading:21505455-Humans,
pubmed-meshheading:21505455-Male,
pubmed-meshheading:21505455-Middle Aged,
pubmed-meshheading:21505455-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Diagnosis of head-and-neck cancer from exhaled breath.
|
|
pubmed:affiliation |
The Department of Chemical Engineering and Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa 32000, Israel.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
